Profound Medical (PROF) Share-based Compensation (IS) (2019 - 2024)
Profound Medical's quarterly Share-based Compensation (IS) came in at $356000.0 in Q3 2024, down 51.03% year-on-year from $727000.0 in Q4 2023, and down 57.72% quarter-over-quarter from $842000.0 in Q2 2024.
Profound Medical has reported Share-based Compensation (IS) for 6 years, with the latest figure at $356000.0 in Q3 2024.
- For the quarter ending Q3 2024, Share-based Compensation (IS) fell 51.03% year-over-year to $356000.0; the trailing twelve-month figure through Sep 2024 stood at $2.9 million (down 22.89% YoY), and the FY2020 full-year result was $3.0 million, up 138.39% from the prior year.
- Share-based Compensation (IS) for Q3 2024 stood at $356000.0, down from $842000.0 in the prior quarter.
- The five-year high for Share-based Compensation (IS) was $3.0 million in Q4 2020, with the low at $356000.0 in Q3 2024.
- Average Share-based Compensation (IS) over 5 years is $1.1 million, with a median of $941000.0 recorded in 2023.
- Year-over-year, Share-based Compensation (IS) jumped 731.21% in 2020 and plunged 51.03% in 2024.
- Tracing PROF's Share-based Compensation (IS) over 5 years: stood at $3.0 million in 2020, then slumped by 33.93% to $2.0 million in 2021, then plunged by 39.47% to $1.2 million in 2022, then tumbled by 39.77% to $727000.0 in 2023, then tumbled by 51.03% to $356000.0 in 2024.
- The last three Share-based Compensation (IS) figures came in at $356000.0 (Q3 2024), $842000.0 (Q2 2024), and $941000.0 (Q1 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (IS) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 35.12 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Profound Medical | 244.28 Mn | 193.99 Mn | 3.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 356,000.00 |
| Sep 30, 2024 | 356,000.00 |
| Jun 30, 2024 | 842,000.00 |
| Jun 30, 2024 | 842,000.00 |
| Mar 31, 2024 | 941,000.00 |
| Mar 31, 2024 | 941,000.00 |
| Sep 30, 2023 | 727,000.00 |
| Sep 30, 2023 | 727,000.00 |
| Jun 30, 2023 | 842,000.00 |
| Jun 30, 2023 | 842,000.00 |
| Mar 31, 2023 | 941,000.00 |
| Mar 31, 2023 | 941,000.00 |
| Sep 30, 2022 | 1.21 Mn |
| Sep 30, 2022 | 1.21 Mn |
| Jun 30, 2022 | 1.59 Mn |
| Jun 30, 2022 | 1.59 Mn |
| Mar 31, 2022 | 875,000.00 |
| Mar 31, 2022 | 875,000.00 |
| Sep 30, 2021 | 1.99 Mn |
| Sep 30, 2021 | 1.99 Mn |
| Jun 30, 2021 | 1.70 Mn |
| Jun 30, 2021 | 1.70 Mn |
| Mar 31, 2021 | 1.10 Mn |
| Mar 31, 2021 | 1.10 Mn |
| Dec 31, 2020 | 3.02 Mn |
| Dec 31, 2020 | 3.02 Mn |
| Sep 30, 2020 | 984,811.00 |
| Sep 30, 2020 | 984,811.00 |
| Jun 30, 2020 | 634,430.13 |
| Jun 30, 2020 | 634,430.13 |
| Mar 31, 2020 | 454,000.00 |
| Mar 31, 2020 | 454,000.00 |
| Dec 31, 2019 | 1.27 Mn |
| Dec 31, 2019 | 1.27 Mn |
| Sep 30, 2019 | 450,149.47 |
| Sep 30, 2019 | 450,149.47 |
| Jun 30, 2019 | 286,844.42 |
| Jun 30, 2019 | 286,844.42 |
| Mar 31, 2019 | 54,619.37 |
| Mar 31, 2019 | 54,619.37 |